Healthcare -
Biotechnology - NASDAQ - GB
$ 0.2829
-4.28 %
$ 72.9 M
Market Cap
-0.92
P/E
ADAP - LONG-TERM DEBT
Long-term Debt ADAP - Adaptimmune Therapeutics plc
69.5 M
LAST VALUE
30.68%
2 YEAR CAGR
8.64%
5 YEAR CAGR
0.00%
10 YEAR CAGR